| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 149, Issue 5 1736-1743, Copyright © 1992 by American Association of Immunologists
ARTICLES |
P Moran, H Beasley, A Gorrell, E Martin, P Gribling, H Fuchs, N Gillett, LE Burton and IW Caras
Genentech, Inc., South San Francisco, CA 94080.
Complement plays a role in activating the inflammatory response and has been implicated in the pathogenesis of some inflammatory diseases. With a view toward controlling unwanted C activation, we evaluated the C regulator, human decay accelerating factor (DAF). Three forms of recombinant DAF were purified from transfected Chinese hamster ovary cells: glycophosphatidylinositol (GPI)-linked membrane DAF (mDAF) extracted from cell membranes; spontaneously shed soluble DAF (sDAF) derived from mDAF; and a novel secreted protein (seDAF), generated by deletion of the signal for GPI attachment. We show that all three molecules inhibit both the classical and alternative pathways of C activation. The following observations indicate that mDAF extracted from Chinese hamster ovary cells reincorporates into RBC membranes via its GPI anchor: 1) cells that are preincubated with mDAF and then washed remain fully protected from C-mediated hemolysis; 2) incubation with phosphatidylinositol-specific phospholipase C abolishes this protection; and 3) sDAF and seDAF, which lack a GPI anchor, do not associate with cell membranes. mDAF is a more potent inhibitor of C- mediated hemolysis than either sDAF or seDAF, suggesting that incorporation into cell membranes greatly enhances the efficiency with which DAF inhibits C activation on the cell surface. In contrast, C activation in the fluid phase is inhibited by sDAF and seDAF, but not by mDAF, possibly due to interference by serum lipoproteins. A reversed passive Arthus reaction in guinea pigs was used to evaluate the ability of recombinant seDAF to inhibit C activation in vivo. When administered at dermal sites, seDAF reduced the severity of immune complex-mediated inflammatory reactions induced by a reversed passive Arthus reaction, as judged by both gross and histologic examination. These data indicate that seDAF may be useful as an anti-inflammatory therapeutic.
This article has been cited by other articles:
|
|
 |
|
  J. W. Hammon Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389. [Full Text]
|
|
|
|
 |
|
 C. E. Bowles, I. Wilkinson, R. A. G. Smith, A. J. G. Moir, H. Montgomery, and R. J. M. Ross Membrane Reinsertion of a Myristoyl-Peptidyl Anchored Extracellular Domain Growth Hormone Receptor Endocrinology, February 1, 2007; 148(2): 824 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kobayashi, K. Matsunami, T. Omori, S. Nakatsu, K. Nakahata, H. Xu, R. Shirakura, M. Fukuzawa, and S. Miyagawa Features of a Newly Cloned Pig C1 Esterase Inhibitor J. Biochem., September 1, 2006; 140(3): 421 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Spitzer, J. Unsinger, D. Mao, X. Wu, H. Molina, and J. P. Atkinson In Vivo Correction of Complement Regulatory Protein Deficiency with an Inhibitor Targeting the Red Blood Cell Membrane J. Immunol., December 1, 2005; 175(11): 7763 - 7770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lukacik, P. Roversi, J. White, D. Esser, G. P. Smith, J. Billington, P. A. Williams, P. M. Rudd, M. R. Wormald, D. J. Harvey, et al. Complement regulation at the molecular level: The structure of decay-accelerating factor PNAS, February 3, 2004; 101(5): 1279 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Menasche and L. H. Edmunds Jr. Extracorporeal Circulation: The Inflammatory Response Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360. [Full Text]
|
|
|
|
|
|
A. Andoh, K. Kinoshita, I. Rosenberg, and D. K. Podolsky Intestinal Trefoil Factor Induces Decay-Accelerating Factor Expression and Enhances the Protective Activities Against Complement Activation in Intestinal Epithelial Cells J. Immunol., October 1, 2001; 167(7): 3887 - 3893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. Goodfellow, R. M. Powell, T. Ward, O. B. Spiller, J. W. Almond, and D. J. Evans Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59 J. Gen. Virol., May 1, 2000; 81(5): 1393 - 1401. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Hamann, C. van Zeventer, A. Bijl, C. Molenaar, K. Tesselaar, and R. A. W. van Lier Molecular cloning and characterization of mouse CD97 Int. Immunol., April 1, 2000; 12(4): 439 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Oshima, N. Okada, T. Joh, M. Sasaki, T. Tada, N. Matsukawa, T. Nomura, H. Ohara, M. Itoh, and H. Okada Decay-Accelerating Factor in Guinea Pig Stomachs Following Ischemia Reperfusion Stress J. Immunol., January 15, 2000; 164(2): 1078 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Sun, C. D. Funk, C. Deng, A. Sahu, J. D. Lambris, and W.-C. Song Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting PNAS, January 19, 1999; 96(2): 628 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wang, M. Nonaka, C. He, N. Okada, I. Nakashima, and H. Okada Functional Differences Among Multiple Isoforms of Guinea Pig Decay-Accelerating Factor J. Immunol., March 15, 1998; 160(6): 3014 - 3022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Shafren, D. J. Dorahy, R. F. Thorne, T. Kinoshita, R. D. Barry, and G. F. Burns Antibody Binding to Individual Short Consensus Repeats of Decay-Accelerating Factor Enhances Enterovirus Cell Attachment and Infectivity J. Immunol., March 1, 1998; 160(5): 2318 - 2323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yu, R. Abagyan, S. Dong, A. Gilbert, V. Nussenzweig, and S. Tomlinson Mapping the Active Site of CD59 J. Exp. Med., February 17, 1997; 185(4): 745 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-f. Zhang, S. Lu, S. L. Morrison, and S. Tomlinson Targeting of Functional Antibody-Decay-accelerating Factor Fusion Proteins to a Cell Surface J. Biol. Chem., July 13, 2001; 276(29): 27290 - 27295. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
